Precision Pathway compared to Traditional Testing:
More accurate non-invasive diagnosis
Fewer unnecessary tests
Reduced long-term risk by increasing preventive therapies5
Patients with non-acute chest pain or the equivalent requiring testing for suspected CAD.No history of Obstructive CAD or CAD testing < 1 year: N=2103
Randomized into one of two pathways.
Randomization stratified by site, PROMISE Minimal Risk Score (Low Risk vs. Elevated Risk), and intended first test (if randomized to Traditional Testing).
Primary Endpoint (1 year)
Death, Nonfatal MI, Cath without obstructive CAD
Death, Nonfatal MI, Unplanned CV Hospitalizations, Radiation, Preventive Medication Use, Cath Yield, Resource Use, Quality of Life